Estrogen Modulates AT1Receptor Gene Expression In Vitro and In Vivo
Authors:
- 9 June 1998
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 97 (22) , 2197-2201
Abstract
Background—The AT1receptor has been implicated in the pathogenesis of hypertension and atherosclerosis. Estrogen deficiency is also associated with cardiovascular diseases. Therefore, we examined the AT1receptor gene expression in ovariectomized rats with and without estrogen replacement therapy and the influence of estrogen on AT1receptor expression in cultured vascular smooth muscle cells.Methods and Results—Rat aortic tissue was examined 5 weeks after ovariectomy. In one group, estrogen (1.7 mg estradiol) was administered during the 5-week period. Functional experiments assessed angiotensin II–induced contraction of aortic rings. AT1receptor mRNA levels were measured by quantitative polymerase chain reaction and Northern blotting. AT1receptor density was assessed by radioligand binding assays. These techniques were also applied in cultured vascular smooth muscle cells. The efficacy of angiotensin II on vasoconstriction was significantly increased in aortas from ovariectomized rats. As assessed by radioligand binding assays, AT1receptor density was increased to 160% without changes in receptor affinity during estrogen deficiency. AT1receptor mRNA levels were consistently increased to 187% in ovariectomized rats compared with sham-operated animals. Estrogen substitution therapy in ovariectomized rats reversed this AT1receptor overexpression. To explore the underlying mechanisms, the direct influence of estradiol on AT1receptor expression was investigated in VSMCs. Estradiol (1 μmol/L) led to a time-dependent downregulation of AT1receptor mRNA, with a maximum of 33.3% at 12 hours. There was a correlative decrease in AT1receptor density.Conclusions—This novel observation of estrogen-induced downregulation of AT1receptor expression could explain the association of estrogen deficiency with hypertension and atherosclerosis, because activation of the AT1receptor plays a key role in the regulation of blood pressure, fluid homeostasis, and vascular cell growth.Keywords
This publication has 18 references indexed in Scilit:
- Effects of moexiprilat on oestrogen‐stimulated cardiac fibroblast growthBritish Journal of Pharmacology, 1997
- Down‐regulation of aortic and cardiac AT1 receptor gene expression in transgenic (mRen‐2) 27 ratsBritish Journal of Pharmacology, 1997
- Effects of Ovariectomy and Estrogen Replacement on Aorta Angiotensin-Converting Enzyme Activity in Rats.The Japanese Journal of Pharmacology, 1997
- Angiotensin II Receptor Pharmacology1994
- Association of Hormone-Replacement Therapy with Various Cardiovascular Risk Factors in Postmenopausal WomenNew England Journal of Medicine, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal womenThe American Journal of Cardiology, 1992
- Menopause and the Risk of Coronary Heart Disease in WomenNew England Journal of Medicine, 1987
- Menopausal estrogen use, high density lipoprotein cholesterol subfractions and liver functionAtherosclerosis, 1983
- The effect of estriol succinate therapy on plasma renin activity and urinary aldosterone in postmenopausal womenMaturitas, 1978